These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36310035)

  • 1. Transport of the Proinflammatory Chemokines C-C Motif Chemokine Ligand 2 (MCP-1) and C-C Motif Chemokine Ligand 5 (RANTES) across the Intact Mouse Blood-Brain Barrier Is Inhibited by Heparin and Eprodisate and Increased with Systemic Inflammation.
    Quaranta DV; Weaver RR; Baumann KK; Fujimoto T; Williams LM; Kim HC; Logsdon AF; Omer M; Reed MJ; Banks WA; Erickson MA
    J Pharmacol Exp Ther; 2023 Jan; 384(1):205-223. PubMed ID: 36310035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
    Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
    Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts.
    Rüster M; Sperschneider H; Fünfstück R; Stein G; Gröne HJ
    Clin Nephrol; 2004 Jan; 61(1):30-9. PubMed ID: 14964455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-C motif chemokine ligand (CCL) production in equine peripheral blood mononuclear cells identified by newly generated monoclonal antibodies.
    Schnabel CL; Wemette M; Babasyan S; Freer H; Baldwin C; Wagner B
    Vet Immunol Immunopathol; 2018 Oct; 204():28-39. PubMed ID: 30596378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta.
    Brown CM; Mulcahey TA; Filipek NC; Wise PM
    Endocrinology; 2010 Oct; 151(10):4916-25. PubMed ID: 20685874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.
    Eugenin EA; Osiecki K; Lopez L; Goldstein H; Calderon TM; Berman JW
    J Neurosci; 2006 Jan; 26(4):1098-106. PubMed ID: 16436595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever.
    de-Oliveira-Pinto LM; Marinho CF; Povoa TF; de Azeredo EL; de Souza LA; Barbosa LD; Motta-Castro AR; Alves AM; Ávila CA; de Souza LJ; da Cunha RV; Damasco PV; Paes MV; Kubelka CF
    PLoS One; 2012; 7(7):e38527. PubMed ID: 22815692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells.
    Haberstroh U; Pocock J; Gómez-Guerrero C; Helmchen U; Hamann A; Gutierrez-Ramos JC; Stahl RA; Thaiss F
    Kidney Int; 2002 Oct; 62(4):1264-76. PubMed ID: 12234296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enhancement of CCL2 and CCL5 by human bone marrow-derived mesenchymal stem/stromal cells might contribute to inflammatory suppression and axonal extension after spinal cord injury.
    Yagura K; Ohtaki H; Tsumuraya T; Sato A; Miyamoto K; Kawada N; Suzuki K; Nakamura M; Kanzaki K; Dohi K; Izumizaki M; Hiraizumi Y; Honda K
    PLoS One; 2020; 15(3):e0230080. PubMed ID: 32155215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS.
    Babcock AA; Kuziel WA; Rivest S; Owens T
    J Neurosci; 2003 Aug; 23(21):7922-30. PubMed ID: 12944523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice.
    Vérité J; Janet T; Chassaing D; Fauconneau B; Rabeony H; Page G
    J Neuroinflammation; 2018 Jun; 15(1):182. PubMed ID: 29898739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease.
    Reale M; Iarlori C; Feliciani C; Gambi D
    J Alzheimers Dis; 2008 Jun; 14(2):147-59. PubMed ID: 18560127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.
    Braunersreuther V; Pellieux C; Pelli G; Burger F; Steffens S; Montessuit C; Weber C; Proudfoot A; Mach F; Arnaud C
    J Mol Cell Cardiol; 2010 Apr; 48(4):789-98. PubMed ID: 19665464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch-Schönlein purpura susceptibility and severity.
    Yu HH; Liu PH; Yang YH; Lee JH; Wang LC; Chen WJ; Chiang BL
    J Formos Med Assoc; 2015 Apr; 114(4):347-52. PubMed ID: 25839768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias.
    Martins E; Brodier H; Rossitto-Borlat I; Ilgaz I; Villard M; Hartley O
    Mol Pharmacol; 2020 Nov; 98(5):599-611. PubMed ID: 32943494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes.
    Vielhauer V; Anders HJ; Mack M; Cihak J; Strutz F; Stangassinger M; Luckow B; Gröne HJ; Schlöndorff D
    J Am Soc Nephrol; 2001 Jun; 12(6):1173-1187. PubMed ID: 11373340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.
    Gyoneva S; Ransohoff RM
    Trends Pharmacol Sci; 2015 Jul; 36(7):471-80. PubMed ID: 25979813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
    Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annulus fibrosus cells express and utilize C-C chemokine receptor 5 (CCR5) for migration.
    Liu W; Liu D; Zheng J; Shi P; Chou PH; Oh C; Chen D; An HS; Chee A
    Spine J; 2017 May; 17(5):720-726. PubMed ID: 28108404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment.
    Bandinelli F; Del Rosso A; Gabrielli A; Giacomelli R; Bartoli F; Guiducci S; Matucci Cerinic M
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S44-9. PubMed ID: 22691208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.